Highlights from the week of 03rd Aug - 10th Aug Takeda ( FDA, Approval ) Takeda receives FDA approval for ORZEYFUL to treat narcolepsy type 1 in adults Moderna ( FDA, Approval ) FDA approves Moderna's seasonal influenza vaccine, mFLUSIVA, for adults aged 50 years and older Reckitt ( FDA, Approval ) FDA provides approval to Reckitt's MUCINEX 12HR Cold & Fever Multi-Symptom, an OTC innovation to manage cold and flu symptoms Replimune ( FDA, Accelerated Approval ) Replimune gets accelerated approval from the FDA for TUDRIQEV, in combination with nivolumab, to treat adults with unresectable advanced cutaneous melanoma All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 03rd August – 10th August in the world of pharma and healthcare!

Uncategorized /

Highlights from the Week of 03rd August – 10th August in the world of pharma and healthcare! Read More »